| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Georgetown University (K.T.W.), Veterans Affairs Medical Center Surgery Service and Surgical Intensive Care Unit (K.T.W., J.C.W.), Veterans Affairs Medical Center Medical Service and Endocrinology Section (E.S.N., R.H.S., K.L.B.), and George Washington University (P.M.S., J.C.W., E.S.N., G.L.S., R.L.G., K.L.B.), Washington, D.C. 20422
Address all correspondence and requests for reprints to: Kevin T. Whang, M.D., University of California-Davis, 4860 Y Street, Suite 3100, Sacramento, California 95817. E-mail: ktwhang{at}yahoo.com
High serum levels of the calcitonin (CT) prohormone, procalcitonin (pro-CT), and its component peptides occur in systemic inflammation and sepsis. Using two different assays, we undertook a prospective study to determine the utility of serum precalcitonin peptides (pre-CT) as markers in this condition.
Twenty-nine patients meeting criteria for the systemic inflammatory response syndrome were studied daily in two intensive care units. Sera were collected, and APACHE II scores were determined until recovery or death. All patients had markedly elevated serum pre-CT. Prognostically, peak values were the most important. The highest values portended mortality, and a lower level could be ascertained below which all patients survived. Peak pre-CT levels were significantly higher in patients with infection documented by blood cultures than in those patients with no documented infection from any source (P < 0.05). Mature CT remained normal or only moderately elevated. Compared with the serum pre-CT levels, receiver operating characteristic curve analysis revealed that the APACHE II scores, although more cumbersome, were better overall predictors of mortality.
Thus, pre-CT is an important serum marker for systemic inflammatory response syndrome and is predictive of outcome. It also provides data concerning the presence of severe infection and may prove to be clinically useful for proactive patient care.
This article has been cited by other articles:
![]() |
M.J. Ruiz-Alvarez, S. Garcia-Valdecasas, R. De Pablo, M. Sanchez Garcia, C. Coca, T.W. Groeneveld, A. Roos, M.R. Daha, and I. Arribas Diagnostic Efficacy and Prognostic Value of Serum Procalcitonin Concentration in Patients With Suspected Sepsis J Intensive Care Med, January 1, 2009; 24(1): 63 - 71. [Abstract] [PDF] |
||||
![]() |
V. Maniaci, A. Dauber, S. Weiss, E. Nylen, K. L. Becker, and R. Bachur Procalcitonin in Young Febrile Infants for the Detection of Serious Bacterial Infections Pediatrics, October 1, 2008; 122(4): 701 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.W. Bassim, R.S. Redman, D.J. DeNucci, K.L. Becker, and E.S. Nylen Salivary Procalcitonin and Periodontitis in Diabetes Journal of Dental Research, July 1, 2008; 87(7): 630 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Christ-Crain and B. Muller Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators Eur. Respir. J., September 1, 2007; 30(3): 556 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Desruisseaux, Nagajyothi, M. E. Trujillo, H. B. Tanowitz, and P. E. Scherer Adipocyte, Adipose Tissue, and Infectious Disease Infect. Immun., March 1, 2007; 75(3): 1066 - 1078. [Full Text] [PDF] |
||||
![]() |
M. Masia, F. Gutierrez, C. Shum, S. Padilla, J. C. Navarro, E. Flores, and I. Hernandez Usefulness of Procalcitonin Levels in Community-Acquired Pneumonia According to the Patients Outcome Research Team Pneumonia Severity Index Chest, October 1, 2005; 128(4): 2223 - 2229. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Skinner, J. A. Moley, W. G. Dilley, K. Owzar, M. K. DeBenedetti, and S. A. Wells Jr. Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia Type 2A N. Engl. J. Med., September 15, 2005; 353(11): 1105 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Canaff and G. N. Hendy Calcium-sensing Receptor Gene Transcription Is Up-regulated by the Proinflammatory Cytokine, Interleukin-1{beta}: ROLE OF THE NF-{kappa}B PATHWAY AND {kappa}B ELEMENTS J. Biol. Chem., April 8, 2005; 280(14): 14177 - 14188. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Becker, E. S. Nylen, J. C. White, B. Muller, and R. H. Snider Jr. Procalcitonin and the Calcitonin Gene Family of Peptides in Inflammation, Infection, and Sepsis: A Journey from Calcitonin Back to Its Precursors J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1512 - 1525. [Full Text] [PDF] |
||||
![]() |
P. Linscheid, D. Seboek, E. S. Nylen, I. Langer, M. Schlatter, K. L. Becker, U. Keller, and B. Muller In Vitro and in Vivo Calcitonin I Gene Expression in Parenchymal Cells: A Novel Product of Human Adipose Tissue Endocrinology, December 1, 2003; 144(12): 5578 - 5584. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kiriyama, Y. Nomura, and Y. Tokumitsu Calcitonin gene expression induced by lipopolysaccharide in the rat pituitary Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1380 - E1384. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Morgenthaler, J. Struck, C. Fischer-Schulz, and A. Bergmann Sensitive Immunoluminometric Assay for the Detection of Procalcitonin Clin. Chem., May 1, 2002; 48(5): 788 - 790. [Full Text] [PDF] |
||||
![]() |
S. Herget-Rosenthal, G. Marggraf, F. Pietruck, J. Husing, M. Strupat, T. Philipp, and A. Kribben Procalcitonin for accurate detection of infection in haemodialysis Nephrol. Dial. Transplant., May 1, 2001; 16(5): 975 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Müller, J. C. White, E. S. Nylén, R. H. Snider, K. L. Becker, and J. F. Habener Ubiquitous Expression of the Calcitonin-I Gene in Multiple Tissues in Response to Sepsis J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 396 - 404. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |